A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of SB204 and Vehicle Gel Once Daily in the Treatment of Acne Vulgaris .

Trial Profile

A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of SB204 and Vehicle Gel Once Daily in the Treatment of Acne Vulgaris .

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors Novan Inc
  • Most Recent Events

    • 07 Jul 2017 According to a Novan Inc media release, post-hoc analysis of this and other study (CTP- 700261357) will be presented at will be presented at the 13th World Congress of Pediatric Dermatology.
    • 07 Jul 2017 Post-hoc analysis of this and other study (CTP-700261357) published in the Novan Inc media release.
    • 06 Mar 2017 According to a Novan media release, company targets submission of new drug application in the first quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top